Ford Motor Company vs Hinge Health Inc. Class A Common Stock — how do they compare? Ford Motor Company trades at $12.12 (market cap $48.05B), while Hinge Health Inc. Class A Common Stock trades at $103.52 (market cap $8.47B). The key difference: Ford Motor Company is far larger — about 5.7× Hinge Health Inc. Class A Common Stock's market cap, and Ford Motor Company pays a 4.98% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ford Motor Company for 105 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| F | HNGE | |
|---|---|---|
Market Cap | $48.05B | $8.47B |
Volume | 32,239,630 | 1,624,526 |
Sector | Consumer Cyclical | Health |
52-Week High | $17.44 | $105.14 |
52-Week Low | $11.21 | $31.17 |
Typical Hold Time | 105 Days | 0 Days |
Enterprise Value | $180.01B | $8.09B |
Dividend Yield | 4.98% | — |
Signals from Pluang's Aura AI — not financial advice
Ford Motor Company (F) trades at $12.10, up 0.83% with bearish technical indicators but mixed fundamentals. The stock shows negative profitability with a -3.93% net margin and -18.31% ROE, though recent quarters saw earnings beats. Operating cash flow remains strong at $21.28B (2025), but sales declined 6.6% in Q3 2026 amid supplier disruptions and model phase-outs. Analyst consensus is mixed with 38.3% buy ratings and a $15.79 price target, suggesting 30% upside potential from current levels.
Ford faces near-term headwinds from production challenges and competitive pressures, but valuation appears attractive with P/E of 11.21 and P/S of 0.26. The company's shift toward hybrids and commercial vehicle strength provides long-term opportunities, though execution risks and debt levels warrant caution. Current price near recent lows offers potential entry for value investors comfortable with automotive sector volatility.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ford Motor Company designs, manufactures, and services cars and trucks. The Company also provides vehicle-related financing, leasing, and insurance through its subsidiary.
Read more on F →Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →